SwePub
Tyck till om SwePub Sök här!
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "hsv:(MEDICIN OCH HÄLSOVETENSKAP) hsv:(Klinisk medicin) ;srt2:(2020);lar1:(lu)"

Sökning: hsv:(MEDICIN OCH HÄLSOVETENSKAP) hsv:(Klinisk medicin) > (2020) > Lunds universitet

  • Resultat 1-10 av 2272
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
1.
  • Norin, Lizette, et al. (författare)
  • Housing adaptations and housing accessibility problems among older adults with long-standing spinal cord injury
  • 2020
  • Ingår i: British Journal of Occupational Therapy. - : SAGE Publications. - 0308-0226 .- 1477-6006. ; , s. 1-10
  • Tidskriftsartikel (refereegranskat)abstract
    • Introduction: Adults with spinal cord injuries are living longer than previously, and a majority are living in ordinary housing in the community. Housing accessibility is important for maintaining independent occupational performance for this population, but knowledge in this area is insufficient. We investigated housing adaptations and current accessibility problems among older adults with long-standing (>10 years) spinal cord injuries. Method: Data from home visits among 122 older adults with spinal cord injuries in Sweden were used. Housing adaptations and environmental barriers were descriptively analysed. Findings: Kitchens, entrances, and hygiene areas were common locations for housing adaptations and environmental barriers that generated accessibility problems. The most common adaptations were ramps, wheelchair-accessible stovetops, and ceiling-lifts. Wall-mounted cupboards and high shelves (kitchen), inaccessible storage areas (outside the dwelling), and a lack of grabbars (hygiene area) generated the most accessibility problems. Conclusion: Despite housing adaptations, there are considerable accessibility problems in the dwellings of older adults with long-standing spinal cord injuries in Sweden, indicating that long-term follow-up of the housing situation of this population is necessary. Focusing on accessible housing as a prerequisite for occupational performance is at the core of occupational therapy, deserving attention on the individual as well as the societal level.
  •  
2.
  • Nozohoor, Shahab, et al. (författare)
  • ABO blood group does not impact incidence or outcomes of surgery for acute type A aortic dissection
  • 2020
  • Ingår i: Scandinavian Cardiovascular Journal. - : Taylor & Francis. - 1401-7431 .- 1651-2006. ; 54:2, s. 124-129
  • Tidskriftsartikel (refereegranskat)abstract
    • Objectives: To evaluate the distribution and impact of ABO blood groups on postoperative outcomes in patients undergoing surgery for acute type A aortic dissection (ATAAD).Design: A total of 1144 surgical ATAAD patients from eight Nordic centres constituting the Nordic consortium for acute type A aortic dissection (NORCAAD) were analysed. Blood group O patients were compared to non-O subjects. The relative frequency of blood groups was assessed with t-distribution, modified for weighted proportions. Multivariable logistic regression was performed to identify independent predictors of 30-day mortality. Cox regression analyses were performed for assessing independent predictors of late mortality.Results: There was no significant difference in the proportions of blood group O between the study populations in the NORCAAD registry and the background population (40.6 (95% CI 37.7-43.4)% vs 39.0 (95% CI 39.0-39.0)%). ABO blood group was not associated with any significant change in risk of 30-day or late mortality, with the exception of blood group A being an independent predictor of late mortality. Prevalence of postoperative complications was similar between the ABO blood groups.Conclusions: In this large cohort of Nordic ATAAD patients, there were no associations between ABO blood group and surgical incidence or outcomes, including postoperative complications and survival.
  •  
3.
  • Taddei, C, et al. (författare)
  • Repositioning of the global epicentre of non-optimal cholesterol
  • 2020
  • Ingår i: Nature. - : Springer Science and Business Media LLC. - 1476-4687 .- 0028-0836. ; 582:7810, s. 73-
  • Tidskriftsartikel (refereegranskat)abstract
    • High blood cholesterol is typically considered a feature of wealthy western countries1,2. However, dietary and behavioural determinants of blood cholesterol are changing rapidly throughout the world3 and countries are using lipid-lowering medications at varying rates. These changes can have distinct effects on the levels of high-density lipoprotein (HDL) cholesterol and non-HDL cholesterol, which have different effects on human health4,5. However, the trends of HDL and non-HDL cholesterol levels over time have not been previously reported in a global analysis. Here we pooled 1,127 population-based studies that measured blood lipids in 102.6 million individuals aged 18 years and older to estimate trends from 1980 to 2018 in mean total, non-HDL and HDL cholesterol levels for 200 countries. Globally, there was little change in total or non-HDL cholesterol from 1980 to 2018. This was a net effect of increases in low- and middle-income countries, especially in east and southeast Asia, and decreases in high-income western countries, especially those in northwestern Europe, and in central and eastern Europe. As a result, countries with the highest level of non-HDL cholesterol—which is a marker of cardiovascular risk—changed from those in western Europe such as Belgium, Finland, Greenland, Iceland, Norway, Sweden, Switzerland and Malta in 1980 to those in Asia and the Pacific, such as Tokelau, Malaysia, The Philippines and Thailand. In 2017, high non-HDL cholesterol was responsible for an estimated 3.9 million (95% credible interval 3.7 million–4.2 million) worldwide deaths, half of which occurred in east, southeast and south Asia. The global repositioning of lipid-related risk, with non-optimal cholesterol shifting from a distinct feature of high-income countries in northwestern Europe, north America and Australasia to one that affects countries in east and southeast Asia and Oceania should motivate the use of population-based policies and personal interventions to improve nutrition and enhance access to treatment throughout the world.
  •  
4.
  • Bryl-Górecka, Paulina, et al. (författare)
  • Bilberry Supplementation after Myocardial Infarction Decreases Microvesicles in Blood and Affects Endothelial Vesiculation
  • 2020
  • Ingår i: Molecular Nutrition & Food Research. - : Wiley-VCH Verlagsgesellschaft. - 1613-4125 .- 1613-4133. ; 64:20
  • Tidskriftsartikel (refereegranskat)abstract
    • Scope: Diet rich in bilberries is considered cardioprotective, but the mechanisms of action are poorly understood. Cardiovascular disease is characterized by increased proatherogenic status and high levels of circulating microvesicles (MVs). In an open-label study patients with myocardial infarction receive an 8 week dietary supplementation with bilberry extract (BE). The effect of BE on patient MV levels and its influence on endothelial vesiculation in vitro is investigated.Methods and results: MVs are captured with acoustic trapping and platelet-derived MVs (PMVs), as well as endothelial-derived MVs (EMVs) are quantified with flow cytometry. The in vitro effect of BE on endothelial extracellular vesicle (EV) release is examined using endothelial cells and calcein staining. The mechanisms of BE influence on vesiculation pathways are studied by Western blot and qRT-PCR. Supplementation with BE decreased both PMVs and EMVs. Furthermore, BE reduced endothelial EV release, Akt phosphorylation, and vesiculation-related gene transcription. It also protects the cells from P2X(7)-induced EV release and increase in vesiculation-related gene expression.Conclusion: BE supplementation improves the MV profile in patient blood and reduces endothelial vesiculation through several molecular mechanisms related to the P2X(7)receptor. The findings provide new insight into the cardioprotective effects of bilberries.
  •  
5.
  • Abdulrasak, Mohammed (författare)
  • EVAR of AAA: Long term outcomes, disease progression and risk stratification
  • 2020
  • Doktorsavhandling (övrigt vetenskapligt/konstnärligt)abstract
    • BackgroundEndovasvular aortic repair (EVAR) is the most commonly utilised technique for the treatment of abdominal aorticaneurysms (AAA) in tertiary referral centers. Detailed long-term outcomes of this technique are relatively scarce,especially for patients presenting symptomatically with AAA. Intra-operatively, proximal type Ia endoleak, involvingblood circulating into the AAA – due to poor proximal seal of the endograft to the aortic neck region – is a fearedcomplication which is usually promptly treated, given its association with post-operative AAA expansion andrupture. Aneurysmatic disease is usually considered a progressive pathology with potential for progression toareas of the aorta beyond the known aneurysmatic segment. Arterial calcifications are established as a marker foratherosclerosis, yet the association of ilio-femoral calcification with post-operative mortality after EVAR is notknown.Aims1. Evaluate the long-term results of EVAR of AAA using a single endograft2. Compare the early and late results of EVAR of symptomatically presenting patients to those treated asymptomatically3. Study the long-term results of intra-operative treatment of type Ia endoleak using large, balloon expandable stents4. Study the progression of aortic disease for patients treated with endovascular means in the postoperative period5. Assess the novel ilio-femoral calcium score as a potential predictor for overall and cardiac-specific mortality after EVARResultsEVAR of AAA yields sustainable results in the long-term, for both symptomatic and asymptomatic patients. Thereis ≈ x4 elevated early mortality in symptomatic patients as compared to asymptomatic ones. Intra-operativetreatment of type Ia endoleaks using large, balloon-expandable stents should be reserved to patients treatedacutely with EVAR. Aortic expansion beyond the sealing zone is relatively uncommon, and seems related to theforce exerted on the aortic wall by the endograft. Ilio-femoral calcium score may predict long-term overall andcardiac mortality after EVAR, albeit the relation is weak. Therefore, further studies are needed to establish thisassociation.
  •  
6.
  • Folkersen, Lasse, et al. (författare)
  • Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals.
  • 2020
  • Ingår i: Nature metabolism. - : Springer Science and Business Media LLC. - 2522-5812. ; 2:10, s. 1135-1148
  • Tidskriftsartikel (refereegranskat)abstract
    • Circulating proteins are vital in human health and disease and are frequently used as biomarkers for clinical decision-making or as targets for pharmacological intervention. Here, we map and replicate protein quantitative trait loci (pQTL) for 90 cardiovascular proteins in over 30,000 individuals, resulting in 451 pQTLs for 85 proteins. For each protein, we further perform pathway mapping to obtain trans-pQTL gene and regulatory designations. We substantiate these regulatory findings with orthogonal evidence for trans-pQTLs using mouse knockdown experiments (ABCA1 and TRIB1) and clinical trial results (chemokine receptors CCR2 and CCR5), with consistent regulation. Finally, we evaluate known drug targets, and suggest new target candidates or repositioning opportunities using Mendelian randomization. This identifies 11 proteins with causal evidence of involvement in human disease that have not previously been targeted, including EGF, IL-16, PAPPA, SPON1, F3, ADM, CASP-8, CHI3L1, CXCL16, GDF15 and MMP-12. Taken together, these findings demonstrate the utility of large-scale mapping of the genetics of the proteome and provide a resource for future precision studies of circulating proteins in human health.
  •  
7.
  • Holmström, Gerd, 1951-, et al. (författare)
  • New modifications of Swedish ROP guidelines based on 10-year data from the SWEDROP register
  • 2020
  • Ingår i: British Journal of Ophthalmology. - : BMJ. - 0007-1161 .- 1468-2079. ; 104:7, s. 943-949
  • Tidskriftsartikel (refereegranskat)abstract
    • BACKGROUND/AIMS:During the last decade, improved neonatal care has resulted in increased survival of the most immature infants and improved health of more mature infants. We hypothesise that this has affected incidence and treatment of retinopathy of prematurity (ROP), enabling guidelines for screening to be modified.METHODS: In Sweden, all infants with gestational age (GA) at birth ≤30 weeks are screened for ROP. Results are registered in a web-based register, Swedish National ROP Register, with a coverage rate of 97%. Incidence of ROP and frequency of treatment, aspects on natural course of ROP and number of examinations, are calculated in relation to GA at birth in infants born during 2008-2017.RESULTS: Of 7249 infants, 31.9% (2310) had ROP and 6.1% (440) were treated. No infant with GA 30 weeks was treated. Incidence of ROP remained similar, but frequency of treatment increased (p=0.023). Over time, GA and birth weight were reduced in infants with ROP and with treated ROP. In the most immature infants, postmenstrual age was lower and postnatal age was higher when any ROP and stage 3 ROP were first detected (p<0.001). At treatment, postmenstrual but not postnatal age of the infant was associated with GA (p<0.001). During the 10-year period, 46 038 examinations were performed.CONCLUSION: Modification of Swedish guidelines is proposed, including only infants with a GA of <30 weeks and postponing the first examination with 1 week in infants with GA 26-29 weeks. This would spare many infants from stressful examinations and reduce eye examinations with at least 20%.
  •  
8.
  • Molvin, John, et al. (författare)
  • Exploration of pathophysiological pathways for incident atrial fibrillation using a multiplex proteomic chip.
  • 2020
  • Ingår i: Open heart. - : BMJ. - 2053-3624 .- 2398-595X. ; 7:1
  • Tidskriftsartikel (refereegranskat)abstract
    • Atrial fibrillation (AF) is the most common arrhythmia and associated with increased morbidity and mortality. Its increasing prevalence calls for novel biomarkers to identify underlying pathophysiological mechanisms as well as patients at risk.Plasma samples from 1694 individuals from the Swedish population-based Malmö Preventive Project (mean age 69.5 years; 29.3% female; mean follow-up time 9.7±3.1 years) were analysed with the Olink proximity extension assay CVD III panel consisting of 92 proteins to identify proteins associated with incident AF or atrial flutter, referred to as incident AF. Incident cases of AF (n=278) were retrieved by linkage to the registers. Participants were followed until the first episode of AF or until censoring by death or emigration. Bonferroni-corrected multivariable Cox regression models adjusted for known risk factors were used to explore possible associations of the 92 proteins and incidence of AF.Multivariable Cox regression analyses of 11 proteins associated with incident AF (mean follow-up time 9.7±3.1 years) after Bonferroni correction confirmed N-terminal pro-B-type natriuretic peptide (HR per 1 SD increment (95% CI) 1.80 (1.58 to 2.04); p=1.2×10-19) as risk marker of incident AF. Further, matrix metalloproteinase-2 (1.22 (1.07 to 1.39); p=0.002) and osteopontin (1.27 (1.12 to 1.44); p=2.7×10-4) were associated with incident AF at follow-up independently of traditional risk markers and NT-proBNP.In a general Swedish population, we confirmed the well-known association of NT-proBNP with incident AF and also identified matrix metalloproteinase-2 and osteopontin as novel risk markers for incident AF, independently of traditional risk factors and NT-proBNP.
  •  
9.
  • Nordanstig, Joakim, et al. (författare)
  • Mortality with Paclitaxel-Coated Devices in Peripheral Artery Disease.
  • 2020
  • Ingår i: The New England journal of medicine. - : Massachusetts Medical Society. - 1533-4406 .- 0028-4793. ; 383, s. 2538-46
  • Tidskriftsartikel (refereegranskat)abstract
    • The results of a recent meta-analysis aroused concern about an increased risk of death associated with the use of paclitaxel-coated angioplasty balloons and stents in lower-limb endovascular interventions for symptomatic peripheral artery disease.We conducted an unplanned interim analysis of data from a multicenter, randomized, open-label, registry-based clinical trial. At the time of the analysis, 2289 patients had been randomly assigned to treatment with drug-coated devices (the drug-coated-device group, 1149 patients) or treatment with uncoated devices (the uncoated-device group, 1140 patients). Randomization was stratified according to disease severity on the basis of whether patients had chronic limb-threatening ischemia (1480 patients) or intermittent claudication (809 patients). The single end point for this interim analysis was all-cause mortality.No patients were lost to follow-up. Paclitaxel was used as the coating agent for all the drug-coated devices. During a mean follow-up of 2.49 years, 574 patients died, including 293 patients (25.5%) in the drug-coated-device group and 281 patients (24.6%) in the uncoated-device group (hazard ratio, 1.06; 95% confidence interval, 0.92 to 1.22). At 1 year, all-cause mortality was 10.2% (117 patients) in the drug-coated-device group and 9.9% (113 patients) in the uncoated-device group. During the entire follow-up period, there was no significant difference in the incidence of death between the treatment groups among patients with chronic limb-threatening ischemia (33.4% [249 patients] in the drug-coated-device group and 33.1% [243 patients] in the uncoated-device group) or among those with intermittent claudication (10.9% [44 patients] and 9.4% [38 patients], respectively).In this randomized trial in which patients with peripheral artery disease received treatment with paclitaxel-coated or uncoated endovascular devices, the results of an unplanned interim analysis of all-cause mortality did not show a difference between the groups in the incidence of death during 1 to 4 years of follow-up. (Funded by the Swedish Research Council and others; ClinicalTrials.gov number, NCT02051088.).
  •  
10.
  • Sigurdsson, Gudmundur Vignir, 1985, et al. (författare)
  • Altered body composition profiles in young adults with childhood-onset inflammatory bowel disease
  • 2020
  • Ingår i: Scandinavian Journal of Gastroenterology. - : Informa UK Limited. - 0036-5521 .- 1502-7708. ; 55:2, s. 169-177
  • Tidskriftsartikel (refereegranskat)abstract
    • Background: Patients with inflammatory bowel disease (IBD) often develop alterations in body composition in terms of their proportions of lean mass and fat mass, as well as reduced bone mineral density (BMD). However, there are limited data on the skeletal muscle index (SMI) and percentage fat (fat %) for young adults with childhood-onset IBD. Our aim was to investigate the body compositions of these patients, with the focus on SMI and fat %. Methods: Body composition was estimated by dual x-ray absorptiometry for 94 young adults with childhood-onset IBD aged 18–27 years, 65 of whom had ulcerative colitis. The Z-scores for SMI, fat %, and BMD were calculated using the normative data from 1,289 individuals with corresponding age. Based on the SMI and fat % Z-scores, each patient was classified as having a body composition profile that was: (i) normal; (ii) obese (fat % Z-score >1); (iii) myopenic (SMI Z-score < −1); or (iv) myopenic-obese. Results: A higher proportion of young adults with childhood-onset IBD had a body composition profile classified as myopenic (24%) or myopenic-obese (9%), as compared to the controls (myopenic [16%, p =.016]; myopenic-obese [2%, p =.002]). Patients with the myopenic or myopenic-obese profile had significantly lower total body BMD Z-scores (−1.3 ± 0.7 and −1.4 ± 0.9, respectively) than patients with the normal profile (−0.2 ± 1.1; p <.001 and p =.004, respectively). Diagnosis of IBD in childhood represented an additional risk for low BMD, regardless of SMI Z-score. Conclusion: Young adults with childhood-onset IBD have a high risk for having altered body composition traits.Summary Young adults with childhood-onset IBD carry a high risk for altered body composition traits. The myopenic and myopenic-obese body composition profiles were more frequently observed in patients with IBD than controls, and these profiles were strongly associated with low BMD.
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 1-10 av 2272
Typ av publikation
tidskriftsartikel (1916)
forskningsöversikt (162)
doktorsavhandling (100)
konferensbidrag (64)
bokkapitel (24)
annan publikation (3)
visa fler...
bok (2)
licentiatavhandling (1)
visa färre...
Typ av innehåll
refereegranskat (2073)
övrigt vetenskapligt/konstnärligt (185)
populärvet., debatt m.m. (14)
Författare/redaktör
Sundquist, Kristina (54)
Sundquist, Jan (51)
Melander, Olle (45)
Hansson, Oskar (45)
Nilsson, Peter M (36)
Erlinge, David (26)
visa fler...
Tumino, Rosario (25)
Engström, Gunnar (24)
Weiderpass, Elisabet ... (24)
Overvad, Kim (22)
Franks, Paul W. (22)
Olsson, Håkan (20)
Rydén, Lisa (20)
Riboli, Elio (20)
Orho-Melander, Marju (20)
Trichopoulou, Antoni ... (19)
Borg, Åke (19)
Groop, Leif (18)
Bruze, Magnus (18)
Nilsson, Jan (18)
Panico, Salvatore (18)
Bruschettini, Matteo (18)
Sacerdote, Carlotta (17)
Borgquist, Signe (17)
Ehinger, Anna (17)
Ekström, Magnus (17)
Jirström, Karin (17)
Palmqvist, Sebastian (17)
Zackrisson, Sophia (16)
Boutron-Ruault, Mari ... (16)
Liedberg, Fredrik (16)
Stomrud, Erik (16)
Rådegran, Göran (16)
Bjermer, Leif (15)
Tjønneland, Anne (15)
Boeing, Heiner (15)
Kühn, Tilman (15)
Karakatsani, Anna (15)
Blennow, Kaj (15)
Englund, Martin (15)
Masala, Giovanna (14)
Sánchez, Maria-José (14)
Ardanaz, Eva (14)
Wareham, Nicholas J. (14)
Norrving, Bo (14)
Mattsson-Carlgren, N ... (14)
Vallon-Christersson, ... (14)
Staaf, Johan (14)
Ricci, Fabrizio (14)
Li, Xinjun (14)
visa färre...
Lärosäte
Karolinska Institutet (336)
Göteborgs universitet (257)
Uppsala universitet (209)
Umeå universitet (145)
Linköpings universitet (127)
visa fler...
Örebro universitet (52)
Linnéuniversitetet (27)
Högskolan Kristianstad (23)
Malmö universitet (19)
Kungliga Tekniska Högskolan (15)
Chalmers tekniska högskola (11)
Högskolan Dalarna (9)
Högskolan i Halmstad (8)
Stockholms universitet (8)
Blekinge Tekniska Högskola (7)
Sophiahemmet Högskola (6)
Jönköping University (5)
Mittuniversitetet (5)
Karlstads universitet (5)
Luleå tekniska universitet (4)
Högskolan i Skövde (4)
Marie Cederschiöld högskola (4)
Sveriges Lantbruksuniversitet (3)
Högskolan i Borås (2)
RISE (2)
Högskolan Väst (1)
Mälardalens universitet (1)
Röda Korsets Högskola (1)
visa färre...
Språk
Engelska (2233)
Svenska (35)
Tyska (2)
Danska (2)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (2272)
Naturvetenskap (72)
Samhällsvetenskap (47)
Teknik (41)
Lantbruksvetenskap (2)
Humaniora (2)
År

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy